Fresenius Medical Care (FMS) Says 66 Abstracts Slated for Presentation at ASN
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/25/2024
- Wall St drops as Meta Platforms, economic data weigh
- Q1 US GDP shows surprise slowing and uncomfortable inflation
- Meta shares dip on softer Q2 revenue guidance, elevated AI spending plans
- Oil steady as US demand concerns balance Middle East conflict risks
- Dollar firmer on higher U.S. inflation; yen sinks vs euro, US currency
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hasbro (HAS) brand strength sees earnings top expectations
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- Meta Platforms, IBM, Caterpillar fall premarket; American Airlines, Chipotle rise
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
Fresenius Medical Care Showcases Breadth and Depth of Clinical Research with Nearly 70 Abstracts Slated for Presentation at the American Society of Nephrology 2016 Kidney Week Meeting
November 17, 2016 2:24 PM ESTClinical Findings Underscore Companys Leadership in Advancing the Science Behind Understanding Renal and Chronic Disease Care
WALTHAM, Mass.--(BUSINESS WIRE)-- Fresenius Medical Care North America (FMCNA), the continents leading provider of kidney care products and services, today announced that the American Society of Nephrology (ASN) accepted a total of 66 abstracts authored by the companys researchers, clinicians, and caregivers for presentation at the 2016 Kidney Week Meeting and publication in the Abstract Supplement of Journal of the American Society of Nephrology (JASN). The general meeting is scheduled from November 17th through... More
